-
Economic Burden Of Primary Biliary Cholangitis (PBC) in Spain
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Assessment of Orphan Drugs in France: Key Insights from CEESP Reviews (2021-2024)
Sep 9, 2025, 16:22 PM -
Understanding the Impact of the NICE Severity Modifier: A Targeted Review of Oncology Submissions
Sep 9, 2025, 16:22 PM -
Lifetime Secondary Healthcare Resource Utilization in Phenylketonuria From Birth to Adulthood in Sweden
Sep 9, 2025, 16:22 PM -
Evaluating the Potential Health and Economic Impact of V116 vs. PCV20 on Invasive Pneumococcal Disease Among Adults in the United Kingdom
Sep 9, 2025, 16:22 PM -
National Implementation of the EU HTA Regulation: Progress and Strategic Developments Across Member States
Sep 9, 2025, 16:22 PM -
Real-World Evidence on the Broader Benefits of GLP-1RA-Based Therapies: A Global Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Clinical and Economic Burden Imposed by Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) in Belgium
Sep 9, 2025, 16:22 PM -
Artificial Intelligence in Evidence Synthesis: A Systematic Review and Meta-Analysis of Emerging Biologics for Improving Skeletal Health in Osteogenesis Imperfecta
Sep 9, 2025, 16:22 PM -
Disease Burden of MASH/MASLD Among People With Obesity in China, Japan, and EU5
Sep 9, 2025, 16:22 PM -
Price-Volume Regulation in France: Alignment Between Negotiated Thresholds With the French Economic Committee for Health Products (CEPS) and Real-World Observations
Sep 9, 2025, 16:22 PM -
APDS Treatment in Germany: Decision Criteria, Costs, and Contribution of Leniolisib to Outcomes
Sep 9, 2025, 16:22 PM -
Feasibility Evaluation of Claims Database: Best Practices and Case Study for a Comparative Analysis of Robotic-Assisted Colorectal Surgery in Germany
Sep 9, 2025, 16:22 PM -
Projected Public Health Benefits of Nirsevimab for RSV Prevention in Infants in Greece
Sep 9, 2025, 16:22 PM -
A Comparison of Methods for Missing Covariates in a Meta-Regression Using Data From a Systematic Review on Oral Epithelial Dysplasia
Sep 9, 2025, 16:22 PM -
Societal and Economic Impact of Long-Acting Injectable Buprenorphine (LAIB) Compared With Standard Opioid Substitution Therapy (OST) in France
Sep 9, 2025, 16:22 PM -
Assessing the Economic Impact of Biosimilars in Europe: A Cost Analysis of Infliximab, Trastuzumab, and Rituximab
Sep 9, 2025, 16:22 PM -
From Data to Decisions: Enhancing Real-World Data Quality: A Survey of Health Data Producers in France
Sep 9, 2025, 16:22 PM -
The Incidence Mortality and Survival of Malignant Hematopoietic Neoplasms in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2000-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Evaluation of the Measurement Properties of the German LupusPRO™ for Swiss-German SLE Patients
Sep 9, 2025, 16:22 PM
